Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-048397
Filing Date
2022-09-01
Accepted
2022-09-01 21:03:14
Documents
1
Period of Report
2022-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6085
  Complete submission text file 0001209191-22-048397.txt   7470
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Issuer) CIK: 0001503802 (see all company filings)

EIN.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AXCELLA HEALTH INC. 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Mitchener Stephen (Reporting) CIK: 0001774519 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36167 | Film No.: 221223034